AstraZeneca CEO: We are 'trailblazing' on vaccine process
The US is investing $1 billion in AstraZeneca's coronavirus vaccine development with Oxford University. "We will start getting substantial doses by September/October," says CEO Pascal Soriot.
AstraZeneca CEO: We are 'trailblazing' on vaccine process
The US is investing $1 billion in AstraZeneca's coronavirus vaccine development with Oxford University. "We will start getting substantial doses by September/October," says CEO Pascal Soriot.